Both in Pharmaceuticals
Galectin Therapeutics vs Rezolute, Inc. Common Stock (NV)
Over the past year GALT returned −7.3% and RZLT returned −56.0%; their daily moves had a correlation of -0.00.
GALT −7.3% RZLT −56.0%Growth of $1, one year, split-adjusted
| Metric | GALT | RZLT |
|---|---|---|
| Price | $3.91 | $4.09 |
| Market cap | $394.3M | $395.6M |
| Today | −0.51% | −2.15% |
| 1 month | −2.7% | −11.5% |
| 6 months | +52.1% | +43.5% |
| Year to date | −6.0% | +73.3% |
| 1 year | −14.1% | −56.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$19.8M | $107.8M |
| Dividend yield | — | — |
| Volatility (60d) | 85.7% | 61.8% |
| Short % of float | 21.4% | 20.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).